You are required to be logged in to access the full website
Click here if you have forgotten your username or password
23 January 2026 - Commercial-stage immunotherapy company ImmunityBio Inc (NASDAQ:IBRX) on Friday announced updated Phase 2 results from QUILT-3.078, evaluating a chemotherapy-free combination of ANKTIVA (nogapendekin alfa inbakicept) plus CAR-NK cell...
23 January 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) on Friday reported positive data from two global phase 3 studies, SHORE and COAST 2, supporting the potential of amlitelimab in patients aged 12 years and older...
23 January 2026 - PhotonPharma Inc, a developer of autologous cancer immunotherapies, announced on Thursday the appointment of William Warren, Ph.D. to its board of directors.PhotonPharma says that Dr. Warren brings more than three decades of experie...
23 January 2026 - Clinical-stage biopharmaceutical company Trevi Therapeutics Inc (Nasdaq:TRVI) announced on Thursday that key results from the Phase 2b CORAL trial of oral nalbuphine ER for the treatment of chronic cough in patients with idiopathic ...
23 January 2026 - Swedish biopharmaceutical company Hansa Biopharma AB (STO:HNSA) announced on Thursday that it has received the 2025 SwedenBIO Award at the SwedenBIO Summit in Stockholm.This award aims to recognise companies that drive scientific pr...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe